Drug firm Granules India on Monday said it is 'voluntarily' recalling ranitidine tablets used to treat ulcers of the stomach and intestines.
"Ranitidine is being recalled by various producers from the US market as they contain unacceptable levels of N nitrosodimethylamine (NDMA). Granules India Ltd is recalling this product voluntarily," the drug firm said in a filing to BSE.
The company further said "the voluntary ongoing recall is a class II recall."
Disclaimer: No Business Standard Journalist was involved in creation of this content